Last updated on April 2018

AiDing Diuresis wIth Tolvaptan (ADD-IT)


Brief description of study

The purpose of this study is to test the use of tolvaptan (commercial name Samsca) when given in addition to intravenous (IV) diuretics early during an episode of acute heart failure. It will be compared to a high dose of IV diuretics alone or the use of metolazone in addition to IV diuretics. The investigators are looking to see if there is improvement in the symptoms and outcomes of persons with acute heart failure.

Detailed Study Description

This is a single-center, randomized trial to assess the effects of 30 mg daily of tolvaptan when given concomitantly with home dose of diuretic (Lasix equivalent) intravenously (IV) versus 5mg daily of metolazone given concomitantly with home dose of diuretic (Lasix equivalent) IV, versus 2.5 times home dose of diuretic (Lasix equivalent) IV in participants hospitalized for acutely decompensated heart failure (ADHF).

Clinical Study Identifier: NCT02646540

Contact Investigators or Research Sites near you

Start Over

Divya Gupta, MD

Emory University Hospital Midtown
Atlanta, GA United States
  Connect »

Divya Gupta, MD

Emory University Hospital
Atlanta, GA United States
  Connect »